Eurosleep, Nova Speciality to study sleep disorders

PTI Mumbai | Updated on March 15, 2013

As more and more lifestyle diseases are attributable to sleep disorders Eurosleep and Nova Speciality Surgery plan to conduct a “research study on sleep disorders” on a sample of Indian population.

Eurosleep, a world leader in treatment of snoring and sleep apnea, has joined hands with Nova Speciality Surgery, a leading chain of centres in India offering speciality surgeries, to conduct a “research study on sleep disorders” on a sample of Indian population.

Sleep disorders are a new area of interest globally, as studies have shown that more and more lifestyle diseases are attributable to sleep disorders, says a release issued today on the occasion of the “World Sleep Day”.

According to Dr Ashim Desai, Senior Consultant, ENT at Nova Specialty Surgery, Mumbai, “Although there is a lot of global data, till now there has been no comprehensive specific data available for the Indian population. Therefore, the need of the hour is to conduct research studies in this area.”

“Globally validated set protocols are being instituted at all centres. Nova’s involvement in this research aims to achieve complete online data integration, in order to generate meaningful insights from the collected data for the Indian population,” said Dr Magne Tvinnereim, Global CEO, Eurosleep.

“With this association, Nova-Eurosleep Sleep Clinics have become the largest provider of diagnostic and therapeutic modalities for the comprehensive study and management of sleep related disorders in the country. It is established simultaneously at five of our centres located in Mumbai, New Delhi, Bengaluru, Hyderabad and Ahmedabad,” said Dr Mahesh Reddy, co-founder of Nova Speciality Surgery.

Sleep apnea is not just a problem of the elderly population as it affects children as well.

Consequences of untreated obstructive sleep apnea among children include failure to thrive, enuresis, attention deficit disorder, behaviour problems, poor academic performance and cardiopulmonary disease, the release said quoting experts in this field.

The most common etiology of obstructive sleep apnea is adenotonsillar hypertrophy. Clinical diagnosis of obstructive sleep apnea is reliable; however, the gold standard evaluation is overnight polysomnography.

Adenotonsillectomy is curative in most patients. The treatment includes use of continuous positive airway pressure and weight loss in obese children, the release added.

Published on March 15, 2013

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like